Covid 19 Research using Clinical Trials (Home Page)
daily syndromic surveillanceWiki
Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation
Correlated Drug Terms (1)
|
Name (Synonyms) |
Correlation |
drug1346 | monthly serologic IgM/G test Wiki | 1.00 |
Correlated MeSH Terms (1)
|
Name (Synonyms) |
Correlation |
D018352 | Coronavirus Infections NIH | 0.05 |
Correlated HPO Terms (0)
|
Name (Synonyms) |
Correlation |
There is one clinical trial.
Clinical Trials
The purpose of this research is to collect information about coronavirus exposures, symptoms,
and health care visits due to the among Atrium Health clients and health care workers.
Participation in this study will involve completing a daily questionnaire which covers
participants coronavirus illness history or symptoms, health care seeking behaviors and
treatments, contact with other sick people, and for health care workers, their use of
personal protective equipment.
NCT04361123 Coronavirus COVID Other: daily syndromic surveillance Diagnostic Test: monthly serologic IgM/G test
Primary Outcomes
Description: Percent of volunteers who are 2019-nCoV Ab test positive
Measure: Seroprevalence of SARS-CoV-2 infection in the general population of North Carolina
Time: baseline
Description: Percent of volunteers who are 2019-nCoV Ab test positive
Measure: Seroprevalence of SARS-CoV-2 infection among health care workers of North Carolina
Time: baseline
Secondary Outcomes
Measure: Cumulative incidence of SARS-CoV-2 infection Time: 12 month
Measure: Monthly incidence of SARS-CoV-2 infection Time: Month 1 thru month 12
Measure: Stratified incidence of SARS-CoV-2 infection by age group Time: Month 1 thru month 12
Measure: Stratified incidence of SARS-CoV-2 infection by sex Time: Month 1 thru month 12
Measure: Stratified incidence of SARS-CoV-2 by season Time: Month 1 thru month 12
Measure: Stratified incidence of SARS-CoV-2 infection by geographic area (zip code) Time: Month 1 thru month 12
Measure: Stratified incidence of SARS-CoV-2 infection by preexisting comorbidities Time: Month 1 thru month 12
Measure: Stratified incidence of SARS-CoV-2 infection by COVID-2 contacts Time: Month 1 thru month 12
Measure: •Stratified incidence of SARS-CoV-2 infection by use of personal protective equipment (PPE) by health workers Time: Month 1 thru month 12
Measure: Relative risk of SARS-CoV-2 infection by age group Time: Month 1 thru month 12
Measure: Relative risk of SARS-CoV-2 infection by sex Time: Month 1 thru month 12
Measure: Relative risk of SARS-CoV-2 infection by season Time: Month 1 thru month 12
Measure: Relative risk of SARS-CoV-2 infection by geographic area (zip code) Time: Month 1 thru month 12
Measure: Relative risk of SARS-CoV-2 infection by preexisting comorbidities Time: Month 1 thru month 12
Measure: Relative risk of SARS-CoV-2 infection by COVID-2 contacts Time: Month 1 thru month 12
Measure: Relative risk of SARS-CoV-2 infection by use of PPE by health workers Time: Month 1 thru month 12
Measure: Incidence of sequelae Time: Month 1 thru month 12
No related HPO nodes (Using clinical trials)